Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NUCYNTA® TABLETS safely and effectively. See full prescribing information for NUCYNTA® TABLETS. NUCYNTA® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
NUCYNTA (tapentadol) tablets are indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see Warnings and Precautions (5.1)], reserve NUCYNTA tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products: Have not been tolerated, or are not expected to be tolerated, Have not provided adequate analgesia, or are not expected to provide adequate analgesia
- generic_name
- tapentadol hydrochloride
- product_names
- tapentadol hydrochloride
- ndc
- 69865-210, 69865-220, 69865-230, 69865-210-02, 69865-210-01, 69865-220-02, 69865-220-01, 69865-230-02, 69865-230-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en